Fusion Pharmaceuticals Inc. (FUSN) Social Stream
FUSION PHARMACEUTICALS INC (FUSN) Price Targets From Analysts
Use the tables below to see what analysts covering FUSION PHARMACEUTICALS INC think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-09 | 6 | $24 | $17 | $20.2 | $3.03 | 566.67% |
| 2021-11-10 | 6 | $20 | $17 | $19 | $3.03 | 527.06% |
| 2022-02-01 | 5 | $20 | $17 | $19 | $3.03 | 527.06% |
| 2022-03-17 | 6 | $20 | $15 | $18.2 | $3.03 | 500.66% |
| 2022-05-10 | 6 | $21 | $15 | $18.4 | $3.03 | 507.26% |
| 2022-05-11 | 6 | $21 | $15 | $18.2 | $3.03 | 500.66% |
| 2022-06-10 | 6 | $19 | $15 | $17.8 | $3.03 | 487.46% |
| 2022-07-06 | 6 | $19 | $8.7 | $16.14 | $3.03 | 432.67% |
| 2022-08-09 | 6 | $19 | $15 | $18 | $3.03 | 494.06% |
| 2022-09-06 | 6 | $19 | $12 | $16.25 | $3.03 | 436.3% |
| 2022-09-16 | 7 | $19 | $10 | $15 | $3.03 | 395.05% |
| 2022-11-08 | 7 | $19 | $10 | $15 | $3.03 | 395.05% |
| 2022-12-01 | 9 | $19 | $6 | $13 | $3.03 | 329.04% |
| 2023-01-27 | 9 | $19 | $6 | $11.714 | $3.03 | 286.6% |
The Trend in the Analyst Price Target
Over the past 17 months, FUSN's average price target has gone down $8.49.
Over the past 51 weeks, FUSN's average upside potential has been 403.2%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-03-18 | 6 | 21 | 15 | 18.4 | 7.35 | 150.34% |
| 2022-04-12 | 6 | 21 | 15 | 18.4 | 7.14 | 157.7% |
| 2022-06-10 | 6 | 19 | 15 | 17.8 | 3.70 | 381.08% |
| 2022-08-09 | 6 | 19 | 15 | 18.0 | 2.04 | 782.35% |
| 2022-11-08 | 7 | 19 | 10 | 15.0 | 2.15 | 597.67% |
FUSN Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1 | 9 | 0 | 0 | 0 | 0 | 9 |
The Trend in the Broker Recommendations
FUSN's average broker recommendation rating improved by 0.17 over the prior 39 weeks.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for FUSN as an investment opportunity.
- FUSION PHARMACEUTICALS INC's upside potential (average analyst target price relative to current price) is greater than 1397.88% of all US stocks.
- In the context of all US stocks, FUSION PHARMACEUTICALS INC's average analyst price target is greater than 307.77% of them.
- FUSION PHARMACEUTICALS INC's number of analysts covering the stock is greater than 1185.64% of stocks in the small market cap category.
- FUSN has a lower variance in analysts' estimates than -338.72% of Pharmaceutical Products stocks.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to FUSION PHARMACEUTICALS INC are PSTX, ITOS, and FRLN.
View All Top Stocks by Price Target
Is FUSN a Buy, Hold or Sell? See the POWR Ratings now!